MedPath

Dexamethasone

Dexamethasone Tablets, USP Rx only

Approved
Approval ID

c4d1e578-a1d2-4d5e-8426-6b2c39f0d9bd

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 26, 2023

Manufacturers
FDA

Preferred Pharmaceuticals, Inc.

DUNS: 791119022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dexamethasone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68788-8467
Application NumberANDA215604
Product Classification
M
Marketing Category
C73584
G
Generic Name
Dexamethasone
Product Specifications
Route of AdministrationORAL
Effective DateJune 26, 2023
FDA Product Classification

INGREDIENTS (7)

DEXAMETHASONEActive
Quantity: 4 mg in 1 1
Code: 7S5I7G3JQL
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
FD&C YELLOW NO. 5Inactive
Code: I753WB2F1M
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dexamethasone - FDA Drug Approval Details